---
figid: PMC9697024__pharmaceuticals-15-01442-g004
pmcid: PMC9697024
image_filename: pharmaceuticals-15-01442-g004.jpg
figure_link: /pmc/articles/PMC9697024/figure/pharmaceuticals-15-01442-f004/
number: Figure 4
figure_title: ''
caption: 'Apigenin decreases serum levels of IL-6 (A; pg/mL, n = 10), IL-1β (B; ng/L,
  n = 10), TNF-α (C; ng/L, n = 10), and IL-18 (D; ng/L, n = 10), and increases serum
  levels of IL-10 (E; pg/mL, n = 8). ##p < 0.01, #p < 0.05 vs. the NC group. ** p
  < 0.01, * p < 0.05 vs. the HC group.'
article_title: Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation
  of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway.
citation: Tianyuan Liu, et al. Pharmaceuticals (Basel). 2022 Nov;15(11):1442.
year: '2022'

doi: 10.3390/ph15111442
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- hyperuricemia
- apigenin
- uric acid
- molecular docking
- JAK2/STAT3 signaling
- renal injury

---
